Key result
Statin treatment was associated with a lower risk of incident atrial fibrillation in postmenopausal women with coronary disease.
Why the study?
Does statin treatment reduce the risk of atrial fibrillation in postmenopausal women with coronary disease?
Cohort (n=2,673)
Yes
Does statin treatment reduce the risk of atrial fibrillation in postmenopausal women with coronary disease?
Answers are grounded in this paper and cite their sources.
Statin use is associated with a significantly lower risk of developing atrial fibrillation in postmenopausal women with coronary disease.
OBJECTIVE: To determine the efficacy of statin treatment in atrial fibrillation (AF) prevention in women. DESIGN: Cohort study using data obtained in the Heart and Estrogen/Progestin Replacement Study (HERS). SETTING: Secondary analysis of a multicentre, randomised controlled clinical trial. PATIENTS: 2673 Postmenopausal women with coronary disease. MAIN OUTCOME MEASURES: AF prevalence at baseline and incident AF over a mean follow-up of 4.1 years. RESULTS: 88 Women with AF were identified: 29 at baseline and 59 during follow-up. Women with AF were significantly less likely to be taking a statin at study enrollment than those without AF (22% vs 37%, p = 0.003). Baseline statin use was associated with a 65% lower odds of having AF at baseline after controlling for age, race, history of myocardial infarction or revascularisation and history of heart failure (odds ratio 0.35, 95% confidence interval (CI) 0.13 to 0.93, p = 0.04). The risk of developing AF during the study among those free from AF at baseline, adjusted for the same covariates, was 55% less for those receiving statin treatment (hazard ratio 0.45, 95% CI 0.26 to 0.78, p = 0.004). CONCLUSIONS: Statin treatment is associated with a lower prevalence and incidence of AF after adjustment for potential confounders in postmenopausal women with coronary disease.
No takes yet. Share an insight, caveat, or question.
Pellegrini et al. (2009) conducted a cohort in Postmenopausal women with coronary disease (n=2,673). Statin treatment vs. No statin treatment was evaluated on Incident atrial fibrillation (HR 0.45, 95% CI 0.26 to 0.78, p=0.004). Statin treatment was associated with a lower risk of incident atrial fibrillation in postmenopausal women with coronary disease.
Synapse has enriched 10 related papers. Consider them for comparative context: